Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)

Clinical Imaging Centre (R.A.C., C.A.S., C.M., I.B., P.S., J.V., M.L., R.N.G., E.A.R.) and Clinical Pharmacology and Discovery Medicine (F.G.) GlaxoSmithKline, London, United Kingdom; Columbia University, New York, New York (M.S.); and Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Verona, Italy (M.P, M.N., L.I., R.G.)